Location: Greenwich, CT
CIK: 0001596452 · Show all filings
Period: Q4 2019 (← Previous) (Next →)
Filing Date: Feb 13, 2020
Total Value: $269M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| HUM | Humana Inc | 27,500 | $10.08M | 3.7% | $207.12 | +45.1% | Cash Securities | 444859102 |
| HCA | HCA Healthcare Inc | 62,500 | $9.238M | 3.4% | $121.55 | +5.0% | Cash Securities | 40412C101 |
| CNC | Centene Corp | 135,000 | $8.487M | 3.2% | $52.87 | +2.6% | Cash Securities | 15135B101 |
| BMY | Bristol-Myers Squibb Co | 130,000 | $8.345M | 3.1% | $45.19 | 0.0% | Cash Securities | 110122108 |
| ELV | Anthem Inc | 27,500 | $8.306M | 3.1% | $206.30 | +22.8% | Cash Securities | 036752103 |
| CI | Cigna Corp | 40,000 | $8.18M | 3.0% | $158.28 | +6.0% | Cash Securities | 125523100 |
| THC | Tenet Healthcare Corp | 215,000 | $8.176M | 3.0% | $24.29 | +23.3% | Cash Securities | 88033G407 |
| UNH | UnitedHealth Group Inc | 27,500 | $8.084M | 3.0% | $217.39 | +8.8% | Cash Securities | 91324P102 |
| BSX | Boston Scientific Corp | 175,000 | $7.914M | 2.9% | $23.58 | +77.4% | Cash Securities | 101137107 |
| UHS | Universal Health Services Inc | 55,000 | $7.89M | 2.9% | $124.96 | +10.8% | Cash Securities | 913903100 |
| DHR | Danaher Corp | 50,000 | $7.674M | 2.8% | $93.99 | +30.8% | Cash Securities | 235851102 |
| SNY | Sanofi ADR | 150,000 | $7.53M | 2.8% | $45.22 | — | Cash Securities | 80105N105 |
| REGN | Regeneron Pharmaceuticals Inc | 20,000 | $7.51M | 2.8% | $359.31 | -6.9% | Cash Securities | 75886F107 |
| ISRG | Intuitive Surgical Inc | 12,500 | $7.389M | 2.7% | $157.72 | +18.7% | Cash Securities | 46120E602 |
| VRTX | Vertex Pharmaceuticals Inc | 32,500 | $7.116M | 2.6% | $126.74 | +59.7% | Cash Securities | 92532F100 |
| MRK | Merck & Co Inc | 75,000 | $6.821M | 2.5% | $48.79 | +38.4% | Cash Securities | 58933Y105 |
| BMRN | BioMarin Pharmaceutical Inc | 80,000 | $6.764M | 2.5% | $81.35 | -7.2% | Cash Securities | 09061G101 |
| LLY | Eli Lilly & Co | 50,000 | $6.572M | 2.4% | $81.68 | +31.7% | Cash Securities | 532457108 |
| GRFS | Grifols SA ADR | 275,000 | $6.405M | 2.4% | $20.40 | — | Cash Securities | 398438408 |
| AZN | AstraZeneca PLC ADR | 125,000 | $6.233M | 2.3% | $40.88 | — | Cash Securities | 046353108 |
| AMGN | Amgen Inc | 25,000 | $6.027M | 2.2% | $182.69 | 0.0% | Cash Securities | 031162100 |
| BIIB | Biogen Inc | 20,000 | $5.935M | 2.2% | $277.46 | 0.0% | Cash Securities | 09062X103 |
| BAX | Baxter International Inc | 70,000 | $5.853M | 2.2% | $52.74 | +39.1% | Cash Securities | 071813109 |
| TMO | Thermo Fisher Scientific Inc | 17,500 | $5.685M | 2.1% | $227.67 | +31.1% | Cash Securities | 883556102 |
| BIO | Bio-Rad Laboratories Inc | 15,000 | $5.55M | 2.1% | $258.11 | +36.6% | Cash Securities | 090572207 |
| IQV | IQVIA Holdings Inc | 35,000 | $5.408M | 2.0% | $147.68 | -1.1% | Cash Securities | 46266C105 |
| ZTS | Zoetis Inc | 40,000 | $5.294M | 2.0% | $115.45 | +2.3% | Cash Securities | 98978V103 |
| SYK | Stryker Corp | 25,000 | $5.249M | 1.9% | $164.07 | +18.4% | Cash Securities | 863667101 |
| ZBH | Zimmer Biomet Holdings Inc | 35,000 | $5.239M | 1.9% | $131.26 | 0.0% | Cash Securities | 98956P102 |
| ABT | Abbott Laboratories | 60,000 | $5.212M | 1.9% | $44.19 | +70.4% | Cash Securities | 002824100 |
| JNJ | Johnson & Johnson | 35,000 | $5.105M | 1.9% | $114.10 | 0.0% | Cash Securities | 478160104 |
| MDT | Medtronic PLC | 45,000 | $5.105M | 1.9% | $80.53 | +14.9% | Cash Securities | G5960L103 |
| ABBV | AbbVie Inc | 50,000 | $4.427M | 1.6% | $64.63 | 0.0% | Cash Securities | 00287Y109 |
| — | Laboratory Corp of America Ho | 25,000 | $4.229M | 1.6% | $158.69 | — | Cash Securities | 50540R409 |
| ALGN | Align Technology Inc | 15,000 | $4.186M | 1.6% | $249.35 | 0.0% | Cash Securities | 016255101 |
| SNN | Smith & Nephew PLC | 75,000 | $3.605M | 1.3% | $48.07 | — | Cash Securities | 83175M205 |
| EW | Edwards Lifesciences Corp | 15,000 | $3.499M | 1.3% | $58.71 | +33.0% | Cash Securities | 28176E108 |
| INCY | Incyte Corp | 40,000 | $3.493M | 1.3% | $80.34 | +6.3% | Cash Securities | 45337C102 |
| ILMN | Illumina Inc | 10,000 | $3.317M | 1.2% | $303.09 | 0.0% | Cash Securities | 452327109 |
| DGX | Quest Diagnostics Inc | 27,500 | $2.937M | 1.1% | $86.79 | +6.5% | Cash Securities | 74834L100 |
| SRPT | Sarepta Therapeutics Inc | 22,500 | $2.903M | 1.1% | $89.74 | +12.5% | Cash Securities | 803607100 |
| AVTR | Avantor Inc | 150,000 | $2.723M | 1.0% | $15.92 | 0.0% | Cash Securities | 05352A100 |
| ALC | Alcon Inc | 45,000 | $2.546M | 0.9% | $59.15 | -4.5% | Cash Securities | H01301128 |
| — | Hill-Rom Holdings Inc | 19,900 | $2.259M | 0.8% | $104.92 | — | Cash Securities | 431475102 |
| — | Seattle Genetics Inc | 19,500 | $2.228M | 0.8% | $70.34 | — | Cash Securities | 812578102 |
| — | Bluebird Bio Inc | 20,000 | $1.755M | 0.7% | $87.75 | — | Cash Securities | 09609G100 |
| CRSP | CRISPR Therapeutics AG | 25,000 | $1.523M | 0.6% | $54.60 | 0.0% | Cash Securities | H17182108 |
| — | Blueprint Medicines Corp | 18,520 | $1.484M | 0.6% | $82.42 | — | Cash Securities | 09627Y109 |
| — | Sage Therapeutics Inc | 15,000 | $1.083M | 0.4% | $137.87 | — | Cash Securities | 78667J108 |
| SPY | PUT - SPY 500 @ 318 EXP 01/17/20 | 5,000 | $825K | 0.3% | — | — | Put | 78462F103 |